• 대한유전성대사질환학회지
• /
• 제2권1호
• /
• pp.85-88
• /
• 2002

저자들은 생후 47일경부터 구토와 산증이 지속되어 시행한 소변 유기산 분석에서 진단된 메칠말로닌산혈증 환아에서 생체 부분 간이식을 시행한 1례에 대해서 문헌 고찰과 함께 보고하는 바이다.

• Pediatric Gastroenterology, Hepatology & Nutrition
• /
• 제4권2호
• /
• pp.249-255
• /
• 2001

저자들은 출생 3개월 경 모유에서 분유로 수유를 바꾸면서 시작된 반복되는 구토, 탈수, 성장장애, 대사성 산증, 고암모니아혈증을 보이는 6개월된 남아에서 메틸말로닐 산혈증으로 진단하고 단백질 제한 식이와 비타민 $B_{12}$ 투여로 호전을 보이고 있는 환아 1례를 경험하였기에 문헌고찰과 함께 보고하는 바이다.

• 대한유전성대사질환학회지
• /
• 제18권1호
• /
• pp.13-17
• /
• 2018

메틸말론산혈증은 선천성 유기산대사질환 중 하나로 증상의 발현시기 및 임상 증상이 매우 다양하며, 장기간의 합병증으로 세뇨관 간질 신염과 만성 신기능 저하, 췌장염, 기저핵 손상, 지능저하가 발생 할 수 있다. 연구자들은 이러한 메틸말론산혈증의 세뇨관 간질신염을 동반한 활동저하 환자에서 파미드로네이트 치료를 통해 고칼슘혈증과 골다공증의 호전을 경험하였기에 보고하는 바이다.

• Childhood Kidney Diseases
• /
• 제7권1호
• /
• pp.96-102
• /
• 2003

저자들은 methymalonic acidemia로 진단된 체중 2.4 kg의 생후 5일된 여아에서 지속적 정정맥 투석 여과법(CVVHDF)을 이용하여 혈역학적 불안정 상태나 특별한 후유증 없이 체내 암모니아를 효과적으로 제거하였기에 보고하는 바이다.

• 대한유전성대사질환학회지
• /
• 제18권2호
• /
• pp.50-54
• /
• 2018

Jehovah's Witnesses do not accept blood transfusions, because of their particular interpretation of the Old and New Testaments. When people with such religious convictions are in need of medical care, their faith and belief may become an obstacle for proper treatment, and pose legal, ethical, and medical challenges for the health care providers. We report two inherited metabolic disorder cases in South Korea where the infants died whilst under medical care because of parental refusal of blood transfusions for religious reasons. Case 1 had methylmalonic acidemia, Down syndrome and associated congenital cardiac anomalies requiring surgery. Case 2 had anemia and methylmalonic acidemia requiring dialysis to treat hyperammonemia and metabolic acidosis. For effective medical management, they needed life-saving blood transfusions. As a part of alternative treatment, Erythropoietin was administered in both cases. As a result, two babies died from their extremely low hemoglobin and hematocrit. The hemoglobin concentrations below 2.7 g/dL without cardiac problem and 5.4 g/dL with cardiac anomaly complicated by pulmonary hypertension are considered life-threatening hemoglobin threshold. The medical professional must respect and accommodate religious beliefs of the patients who can make informed decisions. However, when parents or legal guardians oppose medical treatment of their babies and incompetent care receivers on cultural and religious grounds, the duty to assist and save persons exposed to serious danger, particularly life-threatening events must come first.

• 대한유전성대사질환학회지
• /
• 제14권2호
• /
• pp.174-177
• /
• 2014

단독 메틸말론산혈증은 상염색체 열성으로 유전되는 선천성 유전대사질환으로 methylmalonyl-coenzyme A mutase (MCM)의 결핍에 의해 야기된다. MCM를 코딩하는 MUT 유전자의 돌연변이가 단독 메틸말론산 혈증의 주된 원인이다. 저자들은 생후 15일 여아가 신생아 선별검사를 통하여 C3-acylcarnitine (C3)이 증가되어 있었던 증례를 경험하였다. 환아의 혈장 homocysteine은 정상이었고, 소변 methylmalonic acid는 증가되어 있어서 단독 메틸말론산혈증이 의심되었다. 환아는 단백제한식이와 함께 carnitine 보충요법을 시작하였고, 생후 3개월까지 특별한 증상없이 정상적인 성장을 하고 있다. MUT 유전자 검사를 시행하였으며, 환아는 c.323G>A와 c.1672+2T>C (IVS8 (+2)T>C 변이를 각각 이형접합자로 가지고 있었다. 이중 c.1672+2T>C (IVS8(+2)T>C)은 이전에 보고되지 않은 새로운 돌연변이로 이에 증례 보고하는 바이다.

• Journal of Genetic Medicine
• /
• 제14권2호
• /
• pp.80-85
• /
• 2017

Methylmalonic acidemia (MMA) is an autosomal recessive metabolic disorder characterized by an abnormal accumulation of methylmalonyl-CoA and methylmalonate in body fluids without hyperhomocysteinemia. Cardiac disease is a rarely known lethal complication of MMA, herein, we report a Korean neonate diagnosed with MMA on the basis of biochemical and genetic findings, who developed cardiomyopathy, resulting in sudden death. The patient presented vomiting and lethargy at 3 days of age. Initially, the patient had an increased plasma propionylcarnitine/acetylcarnitine concentration ratio of 0.49 in a tandem mass spectrometry analysis and an elevated ammonia level of $537{\mu}mol/L$. Urine organic acid analysis showed increased excretion of methylmalonate. Subsequent sequence analysis of the methylmalonyl-CoA mutase (MUT) gene revealed compound heterozygous mutations c.323G>A (p.Arg108His) in exon 1 and c.1033_1034del (p. Leu345Serfs*15) in exon 4, the latter being a novel mutation. In summary, this is the first case of MMA and cardiomyopathy in Korea that was confirmed by genetic analysis to involve a novel MUT mutation.

• 대한소아신장학회:학술대회논문집
• /
• 대한소아신장학회 2007년도 춘계학술대회 및 제8회 연수강좌
• /
• pp.12-14
• /
• 2007

• 대한유전성대사질환학회지
• /
• 제4권1호
• /
• pp.30-33
• /
• 2004

• Pediatric Gastroenterology, Hepatology & Nutrition
• /
• 제24권3호
• /
• pp.288-294
• /
• 2021

Purpose: Despite aggressive medical and nutritional management, patients with methylmalonic acidemia (MMA) often suffer from multi-organ damage. Early deceased donor liver transplantation (DDLT) has emerged as an intervention to prevent disease progression. We investigated the efficacy of living donor LT (LDLT) with a potential carrier of MMA and a small volume of graft in patients with MMA as an alternative to DDLT. Methods: Of five patients (three male, two female; median age 5.7 years; range, 1.3-13.7 years), four underwent carrier LDLT, while one underwent non-carrier auxiliary LDLT. All patients received pre- and post-LT continuous renal replacement therapy and were provided with minimal restriction diet according to serum MMA level after LT. MMA levels in the serum and urine, the incidence of metabolic crisis, and clinical findings before and after LT were compared. Results: The survival rate was 100% during 2.2 years of follow up period after LT. In all five cases, MMA titer in the serum after transplantation decreased with less restrictive diet. Metabolic crisis was not observed during the follow-up period. In addition, no patient showed progression of severe renal impairment requiring hemodialysis. Progression of delayed cognitive development was not observed. Social functioning with improved neuropsychiatric development was observed. Conclusion: This study showed that LDLT achieved improved quality of life with less restrictive diet, therefore it could be a feasible alternative option to DDLT for the treatment of patients with MMA, even with an auxiliary LT.